CRMD
CorMedix Inc
NASDAQ: CRMD · HEALTHCARE · BIOTECHNOLOGY
$7.83
-1.70% today
Updated 2026-09-11
Market cap
$609.91M
P/E ratio
3.59
P/S ratio
1.32x
EPS (TTM)
$2.18
Dividend yield
—
52W range
$6 – $13
Volume
1.1M
CorMedix Inc (CRMD) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$7.83
12-Month target
$5.29
2030 Target
$13.86
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.3B | $0.4B | $0.4B | $0.5B | $0.6B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 3.59x (capped 25x) · Margin: 40.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.